Home > Back to Publisher > Report Information

Belgium Drug Delivery Devices Investment Opportunities, Analysis and Forecasts to 2015

Global Markets Direct
September 28, 2009
68 Pages - SKU: GMD2469424

Abstract Table of Contents Search inside this report Related Reports

Countries covered: Belgium

Belgium Drug Delivery Devices Investment Opportunities, Analysis and Forecasts to 2015

Summary

This report is an essential source for in-depth information and data relating to Belgium drug delivery devices market. It also offers detailed and comprehensive coverage of market revenue, volume, distribution and company share information; and the latest news, financial deals and pipeline products information of each of the key sub-segments of the drug delivery devices market in Belgium

Scope

The report provides information on the drug delivery devices market in Belgium.
Details on the key segments and categories such as Inhalation Systems, Needle Free Injections, and Infusion Systems.
Total revenues, products sold, end users, and average pricing.
Market shares of all the key competitors such as AstraZeneca International plc, GlaxoSmithKline plc, Boehringer Ingelheim GmbH, Baxter International Inc., and Hospira, Inc.
Key pipeline products that are set to shape the market, broken down by sector.
Information on the top medical equipment companies in the sector in the country covering business description, strategic analysis, and financial information.
Healthcare structure, regulatory environment, approval process, pricing trends and reimbursement.
Product and brand updates, strategy changes, R&D projects, corporate expansions and contractions and regulatory changes.
Key mergers and acquisitions, partnerships, private equity investments and IPOs.
Customer, hospitals and physicians data.

Reasons to buy

Gain a strong understanding of the drug delivery devices market in Belgium.
Evaluate and compare the attractiveness of the market in the country.
Identify growth segments and opportunities in each industry sector within the country.
Evaluate the pipeline of key products that will change the sector, and identify threats and opportunities before the products are launched in the country.
Analyze the competitiveness of the market in the country and identify hotspots.
Develop strategies based on the latest product, brand, expansion and research and development news in the country.
Plan deal strategies with an understanding of how competitors are financed, and the mergers and partnerships that have shaped the market in the country.
Identify and analyze the strengths and weaknesses of the industry incumbents in the country.

1 Table of Contents: 1.1 List of Tables; 1.2 List of Figures
2 Introduction: 2.1 What Is This Report About?
3 Definitions of the Markets Covered in the Report: 3.1 Drug Delivery Devices; 3.2 Inhalation Systems; 3.3 Infusion Systems
4 Healthcare Sector Review: 4.1 Healthcare Expenditure; 4.2 Healthcare Infrastructure; 4.3 Healthcare Policy
5 Regulation System: 5.1 Medical Equipment Approval Process; 5.2 Notification Fee
6 Pricing and Reimbursement: 6.1 Reimbursement Policies
7 Distribution Structure
8 Drug Delivery Devices In Belgium: 8.1 Drug Delivery Devices, Belgium, Overall Revenue ($ mn), 2000-2015; 8.2 Drug Delivery Devices, Belgium, Category Volume (Units), 2000-2015; 8.3 Drug Delivery Devices, Belgium, Company Share (2007-2008)
9 Infusion Systems In Belgium: 9.1 Infusion Systems Overall Revenue (2000-2015); 9.2 Infusion Systems Overall Volume (2000-2015); 9.3 Infusion Systems Average Price (2000-2015); 9.4 Infusion Systems Distribution Share (2007-2008); 9.5 Infusion Systems, Belgium, Company Share (2007-2008)
10 Inhalation Systems In Belgium: 10.1 Inhalation Systems Overall Revenue (2000-2015); 10.2 Inhalation Systems Overall Volume (2000-2015); 10.3 Inhalation Systems Average Price (2000-2015); 10.4 Inhalation Systems Distribution Share (2007-2008); 10.5 Inhalation Systems, Belgium, Company Share (2007-2008)
11 Overview of Key Companies in Belgium Drug Delivery Devices Market: 11.1 Terumo Corporation; 11.2 Smiths Medical; 11.3 Novartis AG; 11.4 Hospira, Inc.; 11.5 GlaxoSmithKline plc; 11.6 Fresenius Kabi AG; 11.7 Cardinal Health, Inc.; 11.8 Boehringer Ingelheim GmbH; 11.9 Consort Medical plc; 11.10 Baxter International Inc.; 11.11 B. Braun Melsungen AG; 11.12 AstraZeneca PLC; 11.13 H&O Equipments nv
12 Appendix: 12.1 Global Markets Direct Research Methodology; 12.2 Secondary Research; 12.3 Primary Research; 12.4 Models; 12.5 Forecasts; 12.6 Expert Panel Validation; 12.7 Currency Conversion; 12.8 Contact Us; 12.9 Disclaimer
1.1 List of Tables: Table 1: Healthcare Expenditure in Belgium, 2000 - 2007; Table 2: Hospitals and Hospital Beds in Belgium, 2005; Table 3: Number of Doctors by Specialty in Belgium, 2003-2007; Table 4: Number of Hospital Wards by Specialty in Belgium, 2003-2007; Table 5: Medical Equipment Notification Fee in Belgium, 2007; Table 6: Drug Delivery Devices, Belgium, Overall Revenue ($ mn), 2000-2015; Table 7: Drug Delivery Devices, Belgium, Cross-Category Analysis, 2000-2015; Table 8: Drug Delivery Devices, Belgium, Overall Revenue ($ mn), Historic, 2000-2008; Table 9: Drug Delivery Devices, Belgium, Overall Revenue ($ mn), Forecast, 2008-2015; Table 10: Drug Delivery Devices, Belgium, Category Volume (Units), 2000-2015; Table 11: Drug Delivery Devices, Belgium, Category Volume (Units), Historic, 2000-2008; Table 12: Drug Delivery Devices, Belgium, Category Volume (Units), Forecast, 2008-2015; Table 13: Drug Delivery Devices, Belgium, Company Share by Revenue ($ mn), 2007-2008; Table 14: Infusion Systems, Belgium, Revenue ($ mn) by Segment, Historic, 2000-2008; Table 15: Infusion Systems, Belgium, Revenue ($ mn) by Segment, Forecast, 2008-2015; Table 16: Infusion Systems, Belgium, Volume (Units) by Segment, Historic, 2000-2008; Table 17: Infusion Systems, Belgium, Volume (Units) by Segment, Forecast, 2008-2015; Table 18: Infusion Systems, Belgium, Average Price ($), Historic, 2000-2008; Table 19: Infusion Systems, Belgium, Average Price ($), Forecast, 2008-2015; Table 20: Infusion Systems, Belgium, Distribution Share by Revenue ($mn), 2007-2008; Table 21: Infusion Systems, Belgium, Company Share by Revenue ($ mn), 2007-2008; Table 22: Inhalation Systems, Belgium, Revenue ($ mn) by Segment, Historic, 2000-2008; Table 23: Inhalation Systems, Belgium, Revenue ($ mn) by Segment, Forecast, 2008-2015; Table 24: Inhalation Systems, Belgium, Volume (Units) by Segment, Historic, 2000-2008; Table 25: Inhalation Systems, Belgium, Volume (Units) by Segment, Forecast, 2008-2015; Table 26: Inhalation Systems, Belgium, Average Price ($), Historic, 2000-2008; Table 27: Inhalation Systems, Belgium, Average Price ($), Forecast, 2008-2015; Table 28: Inhalation Systems, Belgium, Distribution Share by Revenue ($mn), 2007-2008; Table 29: Inhalation Systems, Belgium, Company Share by Revenue ($ mn), 2007-2008; Table 30: Bespak plc Pipeline Products by Equipment Type; Table 31: Bespak plc Pipeline Products By Development Stage; Table 32: Bespak plc Pipeline Products By Therapy Area; Table 33: USD to Local Currency, Average Exchange Rate 2008
1.2 List of Figures: Figure 1: Total Healthcare Expenditure in Belgium, 2000 - 2007; Figure 2: Government and Private Healthcare Expenditure in Belgium, 2007; Figure 3: Structure of Healthcare System in Belgium, 2007; Figure 4: Flowchart for Classification of Non-invasive Devices in Belgium, 2007; Figure 5: Flowchart for Classification of Invasive Devices in Belgium, 2007; Figure 6: Flowchart for Classification of Invasive Devices in Belgium, 2007; Figure 7: Flowchart for Classification of Invasive Devices in Belgium, 2007; Figure 8: Flowchart for Classification of Invasive Devices in Belgium, 2007; Figure 9: Flowchart for Classification of Active Devices in Belgium, 2007; Figure 10: Flowchart for Classification of Active Devices in Belgium, 2007; Figure 11: Flowchart for Classification of Devices except Non-invasive, Invasive and Active Devices in Belgium, 2007; Figure 12: Conformity Assessment of Class-I Medical Devices in Belgium, 2007; Figure 13: Conformity Assessment of Class-IIa Medical Devices in Belgium, 2007; Figure 14: Conformity Assessment of Class-IIb Medical Devices in Belgium, 2007; Figure 15: Conformity Assessment of Class-III Medical Devices in Belgium, 2007; Figure 16 Drug Delivery Devices, Belgium, Overall Revenue ($ mn), 2000-2015; Figure 17: Drug Delivery Devices, Belgium, Cross-Category Analysis, 2000-2015; Figure 18 Drug Delivery Devices, Belgium, Overall Revenue ($ mn), Historic, 2000-2008; Figure 19 Drug Delivery Devices, Belgium, Overall Revenue ($ mn), Forecast, 2008-2015; Figure 20 Drug Delivery Devices, Belgium, Category Volume (Units), 2000-2015; Figure 21 Drug Delivery Devices, Belgium, Category Volume (Units), Historic, 2000-2008; Figure 22 Drug Delivery Devices, Belgium, Category Volume (Units), Forecast, 2008-2015; Figure 23 Drug Delivery Devices, Belgium, Company Share (%), 2008; Figure 24 Infusion Systems, Belgium, Revenue ($ mn) by Segment, Historic, 2000-2008; Figure 25 Infusion Systems, Belgium, Revenue ($ mn) by Segment, Forecast, 2008-2015; Figure 26 Infusion Systems, Belgium, Company Share (%), 2008; Figure 27 Inhalation Systems, Belgium, Revenue ($ mn) by Segment, Historic, 2000-2008; Figure 28 Inhalation Systems, Belgium, Revenue ($ mn) by Segment, Forecast, 2008-2015; Figure 29 Inhalation Systems, Belgium, Volume (Units) by Segment, Historic, 2000-2008; Figure 30 Inhalation Systems, Belgium, Volume (Units) by Segment, Forecast, 2008-2015; Figure 31 Inhalation Systems, Belgium, Company Share (%), 2008; Figure 32 Global Markets Direct Methodology

More Belgium Reports

D&B Country RiskLine Report: Belgium by Dun & Bradstreet Inc.
This D&B Country RiskLine Report will help you analyze the risks, opportunities and likely payment delays when doing business in this country. It includes ...

Retail Industry Logistics Spending in Belgium to 2014 by Datamonitor
Introduction This databook assesses the prospects for logistics in retail industry. It provides information on total logistics (by value) with respect to nature of sourcing and ...

D&B Country Report: Belgium by Dun & Bradstreet Inc.
D&B Country Report. Comprehensive information for evaluating risks and opportunities when trading or investing in this country. Providing critical information and analysis on ...

Belgium: Country Profile by MarketLine
INTRODUCTION This report provides a detailed analysis on Belgium, providing an overview of its political, economic and business environments, represented in textual, graph and tabular formats. ...

2007 Belgium Industry & Market Outlook report by Barnes Reports
The 2007 Belgium Industry & Market Outlook report is the leading annual publication that describes over 100 major industries in Belgium and 500+ minor industries ...

See all reports like this >>

Belgium Drug Delivery Devices Investment Opportunities, Analysis and Forecasts to 2015

Share this report

Other tasks

Research Assistance

Related Markets

Drug Delivery Reports

Free Alert Me service